Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2021-08-02 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings
2021-08-02 English
FORM 8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A12B filed with the SEC for the registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934. It describes the registration of common stock on The Nasdaq Stock Market LLC. The document includes legal and regulatory language typical of a securities registration form, not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration, which does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. Given the nature of the form and its content, the appropriate classification is Regulatory Filings (RNS). The document length is short and it is not an announcement of a report but the actual filing form for securities registration.
2021-08-02 English
Capital/Financing Update 2021
Capital/Financing Update Classification · 95% confidence The document is a letter from WallachBeth Capital, LLC, the underwriters' representative, addressed to the SEC regarding a Registration Statement on Form S-1. It specifically concurs with the request to accelerate the effective date of the registration statement for an offering. This is related to capital raising activities and the registration of securities for public offering. The document is short (1069 characters) and is a formal communication about the registration process, not the registration statement itself or a financial report. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2021-07-29 English
Capital/Financing Update 2021
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references securities regulation and the Securities Act of 1933. The content is a formal correspondence related to a capital raising registration process, specifically a Form S-1, which is used for initial public offerings or other securities registrations. There is no financial data or report content, only a procedural request. This fits the category of Capital/Financing Update (CAP), as it relates to fundraising and registration of securities.
2021-07-29 English
AMENDMENT NO. 5 TO FORM S-1
Capital/Financing Update Classification · 100% confidence The document is titled 'AMENDMENT NO. 5 TO FORM S-1' and is a registration statement filed with the SEC under the Securities Act of 1933. It includes detailed information about securities registration, offering price, underwriting agreements, indemnification of directors and officers, and other regulatory disclosures typical of a registration statement for a public offering. Form S-1 is a registration statement used for initial public offerings or other securities offerings, which falls under capital raising activities. This is not an annual report, earnings release, or any other financial report but a regulatory filing related to capital markets and securities issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains substantive content, not just an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear identification of the form and content.
2021-07-29 English
AMENDMENT NO. 4 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is titled 'AMENDMENT NO. 4 TO FORM S-1' and is a registration statement filed with the SEC under the Securities Act of 1933. It includes detailed information about a securities offering, including the number of units, pricing, underwriting details, and legal disclaimers. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, which is a capital raising activity. The document is not an annual report, earnings release, or any other financial report but rather a filing related to capital raising. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, not just an announcement or a brief notice, so it is not a Report Publication Announcement or Regulatory Filing. Hence, the classification is CAP with high confidence.
2021-07-28 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.